Select Sleep Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Delta wave activity disruption during sleep may be a useful metric to identify those at an increased risk for cardiovascular disease and mortality, a new study suggested.

Zolpidem and behavior therapy each reduce daytime symptoms of insomnia such as fatigue, functional impairments, and depressive symptoms, data suggested.

A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.

Researchers presented data about the relationship between sleep and outcomes such as response to vaccination and recovery from COVID-19.

A genetic predisposition to getting less than optimal sleep was associated with subsequent depression.